Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Did the Outcome of Sicke Cell Disease Babies Screened at Birth Improved from 2000? a Single Center Experience

Clemence Peresse, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Beatrice Gulbis, MD PhD, Sarah Wambacq, Alina Ferster, MD

Blood (2019) 134 (Supplement_1): 4847.

https://doi.org/10.1182/blood-2019-130294

Published: 2019

Journal Articles

Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced

Michael Wang, Beng Fuh, MD, Philip Maes, MD, Maria Eva Mingot-Castellano, PhD MD, Rubén Berrueco, MD, Phu-Quoc Le, MD PhD, Stephan Rauchensteiner, Cristina Santoro, MD PhD

Blood (2018) 132 (Supplement 1): 5045.

https://doi.org/10.1182/blood-2018-99-116622

Published: 2018

Journal Articles

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Geoffrey Bourg, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Safiatou Diallo, MD, Sabine Amah, MD, Christine Devalck, MD, Catherine Heijmans, MD, Laurence Hanssens, MD, Rossana Pavone, MD, Malou Ngalula Mujinga, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2018-99-118373

Published: 2018

Journal Articles

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Phu-Quoc Le, MD PhD, Beatrice Gulbis, MD PhD, Laurence Dedeken, MD, Laurence Rozen, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Fleur Samantha Benghiat, Andre Efira, MD, Marie-Françoise Dresse, MD PhD, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2018-99-119319

Published: 2018

Journal Articles

Determinants of Prophylaxis Regimen Choice for Patients with Hemophilia Α Switching to Bay 81-8973: Real World Findings from the Taurus Non-Interventional Study

Beng Fuh, MD, Cristina Santoro, MD PhD, Philip Maes, MD, Maria Eva Mingot-Castellano, PhD MD, Rubén Berrueco, MD, Phu-Quoc Le, MD PhD, Stephan Rauchensteiner, Michael Wang

Blood (2018) 132 (Supplement 1): 5023.

https://doi.org/10.1182/blood-2018-99-116737

Published: 2018

Journal Articles

No Impact of Pharmacokinetics Profiles on the Clinical and Biological Response to Hydroxyurea in Children with Sickle Cell Disease

Maria Karimi, MD, Anar Rodriguez Cheang, Laurence Dedeken, MD, Phu-Quoc Lê, MD, Laurence Rozen, Malou Ngalula Mujinga, Bernard Wenderickx, Alina Ferster, MD

Blood (2017) 130 (Supplement 1): 3549.

https://doi.org/10.1182/blood.V130.Suppl_1.3549.3549

Published: 2017

Journal Articles

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

Blood (2017) 130 (Supplement 1): 2244.

https://doi.org/10.1182/blood.V130.Suppl_1.2244.2244

Published: 2017

Journal Articles

Safe Deep Sedation with Midazolam and Propofol for Cerebral MRI in Young Children with Sickle Cell Disease Is Safe: A Single Center Experience in Belgium

Cécile Callewaert, MD, Laurence Dedeken, MD, Françoise De Groote, MD, Laurence Rozen, Phu-Quoc Lê, MD, Sophie Huybrechts, MD, Safiatou Diallo, MD, Christine Devalck, MD, Catherine Heijmans, MD, Andrée De Ville, MD, Alina Ferster, MD

Blood (2016) 128 (22): 1324.

https://doi.org/10.1182/blood.V128.22.1324.1324

Published: 2016

Journal Articles

Successful Transition from Paediatric to Adult Care in Sickle Cell Disease: An Experience in a Belgian Center

Tracy Vandergraesen, MD, Laurence Dedeken, MD, Andre Efira, MD PhD, Phu Quoc Lê, MD, Sophie Huybrechts, MD, Safiatou Diallo, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Agnes Azerad, MD, Alina Ferster, MD

Blood (2016) 128 (22): 2495.

https://doi.org/10.1182/blood.V128.22.2495.2495

Published: 2016

Journal Articles

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Phu-Quoc Lê, MD, Alina Ferster, MD, Laurence Dedeken, MD, Laurence Rozen, PharmD, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Françoise Dresse, MD PhD, André Efira, MD, Samantha Benghiat, MD PhD, Sophie Dupont, MD, Beatrice Gulbis, MD PhD

Blood (2014) 124 (21): 4935.

https://doi.org/10.1182/blood.V124.21.4935.4935

Published: 2014

Journal Articles

Clinical Benefit and Costs’ Evaluation of Erythocytapheresis Compared to Manual Exchange Transfusion for Children with Sickle Cell Disease: A Single Center Experience

Laurence Dedeken, MD, Phu Quoc Lê, MD, Laurence Rozen, PharmD, Hanane El Kenz, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Delphine Sauvage, MD, Catherine Heijmans, MD, Alina Ferster, MD

Blood (2014) 124 (21): 4091.

https://doi.org/10.1182/blood.V124.21.4091.4091

Published: 2014

Journal Articles

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Phu-Quoc Lê, MD, Laurence Dedeken, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, Samantha Benghiat, MD, André Efira, MD, Marie-Francoise Dresse, MD, Sophie Dupont, MD, Alina Ferster, MD

Blood (2013) 122 (21): 2231.

https://doi.org/10.1182/blood.V122.21.2231.2231

Published: 2013

Journal Articles

Thrombin Generation Test During Asparaginase Treatment In Children With Acute Lymphoblastic Leukemia

Laurence Rozen, PharmD, Denis F Noubouossie, MD, Laurence Dedeken, MD, Sophie Huybrechts, MD, Phu-Quoc Le, MD, Alina Ferster, MD, Anne Demulder, MD, PHD

Blood (2013) 122 (21): 2367.

https://doi.org/10.1182/blood.V122.21.2367.2367

Published: 2013

Journal Articles

Characteristics of Sickle Cell Disease Children Having Elevated Thrombin Potential

Denis F Noubouossie, MD, Phu-Quoc Le, MD, Laurence Rozen, PharmD, Dominique Willems, MD, Mahadeb Bhavna, MD, Malou Ngalula Mujinga, Anne Demulder, MD, PHD, Alina Ferster, MD

Blood (2012) 120 (21): 4762.

https://doi.org/10.1182/blood.V120.21.4762.4762

Published: 2012

Journal Articles

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Laurence Dedeken, MD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christiane Vermylen, MD, PhD, Sophie Huybrechts, MD, Christine Devalck, MD, Frederic Cotton, PhD, Ba Cuong Nguyen, Françoise Vertongen, MD, PhD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 4757.

https://doi.org/10.1182/blood.V120.21.4757.4757

Published: 2012

Journal Articles

Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

Rudy Chapusette, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, France Ziereisen, MD, Laurence Hanssens, MD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 2107.

https://doi.org/10.1182/blood.V120.21.2107.2107

Published: 2012

Journal Articles

Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Childhood: A Single Center Experience with 45 Patients

Laurence Dedeken, MD, Phu-Quoc Le, MD, Nadira Azzi, MD, Cecile Brachet, MD, Catherine Heijmans, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Ngalula Mujinga Malou, Alina Ferster, MD

Blood (2011) 118 (21): 3103.

https://doi.org/10.1182/blood.V118.21.3103.3103

Published: 2011

Journal Articles

Towards An Improvement of the Coagulation Imbalance in Sickle Cell Disease After Hematopoietic Stem Cell Transplantation: A Preliminary Study

Denis F Noubouossie, MD, Jan Emmerechts, MD, France Debaugnies, PharmD, Phu-Quoc Le, MD, Laurence Rozen, PharmD, Marc F. Hoylaerts, PhD, Anne Demulder, MD, PHD, Alina Ferster, MD

Blood (2011) 118 (21): 4840.

https://doi.org/10.1182/blood.V118.21.4840.4840

Published: 2011

Journal Articles

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Phu-Quoc Le, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Ba-Cuong Nguyen, Malou Ngalula Mijinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 4816.

https://doi.org/10.1182/blood.V116.21.4816.4816

Published: 2010

Journal Articles

Pica In Children with Sickle Cell Disease

Michel Aloni, MD, Pauline Lecerf, Catherine Heijmans, MD, Phu-Quoc Le, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Malou Ngalula Mujinga, nurse, Alina Ferster, MD

Blood (2010) 116 (21): 4807.

https://doi.org/10.1182/blood.V116.21.4807.4807

Published: 2010

NARROW

Did the Outcome of Sicke Cell Disease Babies Screened at Birth Improved from 2000? a Single Center Experience

Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Determinants of Prophylaxis Regimen Choice for Patients with Hemophilia Α Switching to Bay 81-8973: Real World Findings from the Taurus Non-Interventional Study

No Impact of Pharmacokinetics Profiles on the Clinical and Biological Response to Hydroxyurea in Children with Sickle Cell Disease

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

Safe Deep Sedation with Midazolam and Propofol for Cerebral MRI in Young Children with Sickle Cell Disease Is Safe: A Single Center Experience in Belgium

Successful Transition from Paediatric to Adult Care in Sickle Cell Disease: An Experience in a Belgian Center

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Clinical Benefit and Costs’ Evaluation of Erythocytapheresis Compared to Manual Exchange Transfusion for Children with Sickle Cell Disease: A Single Center Experience

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Thrombin Generation Test During Asparaginase Treatment In Children With Acute Lymphoblastic Leukemia

Characteristics of Sickle Cell Disease Children Having Elevated Thrombin Potential

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Childhood: A Single Center Experience with 45 Patients

Towards An Improvement of the Coagulation Imbalance in Sickle Cell Disease After Hematopoietic Stem Cell Transplantation: A Preliminary Study

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Pica In Children with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only